Our Mission

At Alector, we are on a mission to slow the progression of neurodegenerative diseases and to one day prevent their occurrence.

Today more than 55 million people are living with dementia, with over 10 million new cases diagnosed each year. Alzheimer’s disease alone affects approximately 24 million people worldwide. Beyond dementia, more than 10 million people globally are living with Parkinson’s disease and as we age, the likelihood of a neurodegenerative diagnosis increase. Neurogenerative conditions, marked by the progressive damage and loss of nerve cells, remain without a cure.

We envision a world where individuals retain their full cognitive functions throughout life – a world where neurodegeneration is no longer inevitable.

Our mission is grounded in scientific innovation. With a deep commitment to understanding the underlying mechanisms of neurodegenerative diseases, we are focused on developing therapies that remove toxic proteins, replace missing proteins, and restore the function of immune and nerve cells. Ultimately, our work is for the millions of patients and families living with the daily reality of neurodegeneration — and we are committed to advancing the science that could change that reality.